Dublin, OH, United States of America

William C Zimlich

This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignees: Battelle Pulmonary Therapeutics, Inc., Activaero Gmbh, Battelle Memorial Institute. Active years: 2001-2015.


% Patents Active = 71.4


Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 297(Granted Patents)


Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of William C. Zimlich

Introduction

William C. Zimlich is an accomplished inventor based in Dublin, OH (US). He holds a total of 7 patents that reflect his significant contributions to the field of medical devices, particularly in respiratory health.

Latest Patents

One of his latest inventions is a mobile inhaler device. This device is designed to administer aerosolized particles to specific areas of the lungs. The invention focuses on the targeted delivery of aerosolized pharmaceutical formulations, enhancing the effectiveness of treatments. It includes methods for regulating aerosolizing parameters to ensure precise delivery. Additionally, the invention encompasses systems for disease management, where aerosolizing parameters can be adjusted based on monitoring various health parameters.

Career Highlights

Throughout his career, Zimlich has worked with notable organizations such as Battelle Pulmonary Therapeutics, Inc. and Battelle Memorial Institute. His work in these institutions has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Zimlich has collaborated with esteemed colleagues, including Richard D. Peters and Michael J. Brooker. These partnerships have contributed to the advancement of his inventions and the overall impact of his work in the medical field.

Conclusion

William C. Zimlich's contributions to medical device innovation, particularly in respiratory health, demonstrate his commitment to improving patient care. His inventions continue to pave the way for advancements in targeted drug delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…